by Grace Tucker | Nov 8, 2012
Medical devices are progressively using technology without recognizing the risks that accompany it. The U.S. Government Accountability Office recently found “several information security threats that [could] exploit vulnerabilities in active implantable medical...
by Grace Tucker | Nov 2, 2012
Per in-Pharma Technologist.com, Regulation Health Canada first publicly introduced the idea of extending good manufacturing practice laws to active pharmaceutical ingredients in the September 2012 publication of the Canada Gazette. It was only this past week that...
by Grace Tucker | Oct 29, 2012
On October 17, 2012, FDA announced another development in the MDUFA III implementation. The publication of the draft guidance on the eCopy program describes how FDA will initiate implementation once the guidance is finalized. An eCopy serves as the duplicate for the...
by Grace Tucker | Oct 17, 2012
A recent article in The Wall Street Journal explained the innovative idea of using the web to monitor post-trial patients. The article shared that researchers can analyze patient comments in online chats and websites to watch for drug reactions. By monitoring the web,...
by Grace Tucker | Oct 8, 2012
Ten of the world’s largest drug makers joined together to create Trancelerate Biopharma, a new nonprofit generated from a routine meeting of drug company research chiefs. The goal of this new and innovative organization is to reduce duplicative work, therefore...
